DK2306202T3 - Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom - Google Patents

Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom

Info

Publication number
DK2306202T3
DK2306202T3 DK10196249.6T DK10196249T DK2306202T3 DK 2306202 T3 DK2306202 T3 DK 2306202T3 DK 10196249 T DK10196249 T DK 10196249T DK 2306202 T3 DK2306202 T3 DK 2306202T3
Authority
DK
Denmark
Prior art keywords
detecting
immunoglobulins
bound
monitoring
plasma cell
Prior art date
Application number
DK10196249.6T
Other languages
Danish (da)
English (en)
Inventor
Arthur Bradwell
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Application granted granted Critical
Publication of DK2306202T3 publication Critical patent/DK2306202T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK10196249.6T 2005-01-27 2006-01-26 Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom DK2306202T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
EP06703629.3A EP1842071B3 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease

Publications (1)

Publication Number Publication Date
DK2306202T3 true DK2306202T3 (da) 2014-02-10

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10196249.6T DK2306202T3 (da) 2005-01-27 2006-01-26 Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom

Country Status (11)

Country Link
US (3) US7897353B2 (https=)
EP (2) EP1842071B3 (https=)
JP (3) JP5431674B2 (https=)
AT (1) ATE502302T1 (https=)
DE (1) DE602006020688D1 (https=)
DK (1) DK2306202T3 (https=)
ES (2) ES2455440T3 (https=)
GB (1) GB0501741D0 (https=)
PL (1) PL2306202T3 (https=)
PT (1) PT2306202E (https=)
WO (1) WO2006079816A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) * 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
ES2702183T3 (es) * 2013-03-15 2019-02-27 Mayo Found Medical Education & Res Identificación y monitorización de inmunoglobulinas monoclonales por masa molecular
DE112014004109B4 (de) 2013-09-06 2021-05-20 Sensor Electronic Technology Inc. Diffuse Ultraviolettbeleuchtung
WO2015154052A1 (en) 2014-04-04 2015-10-08 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
EP3681907A4 (en) 2017-09-13 2021-07-07 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
EP0044219A1 (en) 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
EP0862584B1 (en) * 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
EP1131344B1 (en) * 1998-11-19 2005-08-03 ELAN CORPORATION, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
US20040163137A1 (en) * 2001-02-20 2004-08-19 Caroline Barry PG-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
US20050154192A1 (en) * 2001-11-27 2005-07-14 Kamon Shirakawa Anti-il13 receptor alpha1 neutralizing antibody
US20040018576A1 (en) 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
CA2515699C (en) * 2003-02-10 2015-01-27 Aya Jakobovits Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU2004213053C1 (en) * 2003-02-20 2009-07-16 Seagen Inc. Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
EP1613658B1 (en) * 2003-04-02 2012-03-14 F. Hoffmann-La Roche AG Antibodies against insulin-like growth factor i receptor and uses thereof
WO2005062044A1 (ja) * 2003-11-19 2005-07-07 Yamasa Corporation ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
ATE502302T1 (de) 2011-04-15
US8592561B2 (en) 2013-11-26
JP2013147499A (ja) 2013-08-01
EP1842071A1 (en) 2007-10-10
EP1842071B3 (en) 2014-02-26
ES2455440T3 (es) 2014-04-15
GB0501741D0 (en) 2005-03-02
WO2006079816A1 (en) 2006-08-03
JP2008528995A (ja) 2008-07-31
EP2306202A1 (en) 2011-04-06
US20110177535A1 (en) 2011-07-21
US20080166742A1 (en) 2008-07-10
US8415110B2 (en) 2013-04-09
JP6007134B2 (ja) 2016-10-12
EP2306202B1 (en) 2013-12-18
EP1842071B1 (en) 2011-03-16
ES2365626T7 (es) 2014-06-04
PL2306202T3 (pl) 2014-05-30
PT2306202E (pt) 2014-02-27
ES2365626T3 (es) 2011-10-07
US20110177977A1 (en) 2011-07-21
US7897353B2 (en) 2011-03-01
JP2014025950A (ja) 2014-02-06
DE602006020688D1 (de) 2011-04-28
JP5431674B2 (ja) 2014-03-05
JP5715671B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
DK2306202T3 (da) Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom
ATE410684T1 (de) Molekular-modifikations-assays
ATE449337T1 (de) Assay
WO2009058902A3 (en) Methods and devices for analyte detection
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
WO2010096674A3 (en) A+ biomarker assays
CA2690718A1 (en) Device, kit and method for hookworm antigen capture and detection
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
Chocarro-Ruiz et al. Interferometric nanoimmunosensor for label-free and real-time monitoring of Irgarol 1051 in seawater
WO2005047863A3 (en) Substrates, devices, and methods for cellular assays
WO2008076367A3 (en) Polymer-protein substrates for immunosorbent fluorescence assays
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
ATE520029T1 (de) Biochemisches gerät und nachweisverfahren
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2002079783A3 (en) Method and device for testing for bence-jones protein
EP1258729A3 (en) A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
ATE405830T1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
JP2018519525A5 (https=)
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου